Aptus Pharma Limited has announced a significant bonus issue in the ratio of 3:2, meaning shareholders will receive three new equity shares for every two held. The move, approved at the March 24, 2026 board meeting, reflects strong reserves and aims to enhance investor value.
Aptus Pharma Limited has finalized key resolutions at its recent board meeting, including an increase in authorized share capital and a bonus issue of equity shares. The company will seek shareholder approval via postal ballot, with e-voting facilitated by CDSL.
Increase In Authorized Share Capital
The board approved raising the company’s authorized share capital, subject to member approval, to support future growth and capital requirements.
Bonus Equity Shares In 3:2 Ratio
Shareholders will receive three bonus shares for every two fully paid-up shares held, capitalizing ₹10.29 crore from the Securities Premium Account. This will expand paid-up capital from ₹6.86 crore to ₹17.15 crore.
Postal Ballot And E-Voting
The company will conduct a postal ballot with remote e-voting to secure shareholder approval. A scrutinizer has been appointed to ensure transparency.
Key Highlights
-
Bonus issue ratio: 3:2
-
Total bonus shares: 1,02,90,000 equity shares
-
Capitalization amount: ₹10.29 crore from Securities Premium
-
Paid-up capital post issue: ₹17.15 crore
-
Bonus shares to be credited by May 23, 2026
Sources: Aptus Pharma Limited Board Meeting Outcome, SEBI filings